ATE191715T1 - Verfahren zur herstellung von cis (+) 3-(4,6- dihydroxychroman-3-ylmethyl)-4-methoxyanilin, und zwischenprodukte - Google Patents

Verfahren zur herstellung von cis (+) 3-(4,6- dihydroxychroman-3-ylmethyl)-4-methoxyanilin, und zwischenprodukte

Info

Publication number
ATE191715T1
ATE191715T1 AT95932147T AT95932147T ATE191715T1 AT E191715 T1 ATE191715 T1 AT E191715T1 AT 95932147 T AT95932147 T AT 95932147T AT 95932147 T AT95932147 T AT 95932147T AT E191715 T1 ATE191715 T1 AT E191715T1
Authority
AT
Austria
Prior art keywords
methoxyaniline
ylmethyl
dihydroxychroman
compounds
cis
Prior art date
Application number
AT95932147T
Other languages
English (en)
Inventor
George J Quallich
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE191715T1 publication Critical patent/ATE191715T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT95932147T 1994-11-30 1995-10-06 Verfahren zur herstellung von cis (+) 3-(4,6- dihydroxychroman-3-ylmethyl)-4-methoxyanilin, und zwischenprodukte ATE191715T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/346,955 US5539128A (en) 1994-11-30 1994-11-30 Processes and intermediates for preparing cis(+)3-[4,6-dihydroxy chroman-3-ylmethyl]-4-methoxyaniline
PCT/IB1995/000846 WO1996016955A1 (en) 1994-11-30 1995-10-06 Processes and intermediates for preparing cis(+)3-[4,-6-dihydroxychroman-3-ylmethyl]-4-methoxyaniline

Publications (1)

Publication Number Publication Date
ATE191715T1 true ATE191715T1 (de) 2000-04-15

Family

ID=23361728

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95932147T ATE191715T1 (de) 1994-11-30 1995-10-06 Verfahren zur herstellung von cis (+) 3-(4,6- dihydroxychroman-3-ylmethyl)-4-methoxyanilin, und zwischenprodukte

Country Status (12)

Country Link
US (1) US5539128A (de)
EP (1) EP0794951B1 (de)
JP (1) JP3041049B2 (de)
AT (1) ATE191715T1 (de)
CA (1) CA2204604C (de)
DE (1) DE69516305T2 (de)
DK (1) DK0794951T3 (de)
ES (1) ES2144628T3 (de)
FI (1) FI972284A7 (de)
GR (1) GR3033608T3 (de)
PT (1) PT794951E (de)
WO (1) WO1996016955A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK31399A3 (en) * 1996-09-16 2000-05-16 Pfizer Processes and intermediates for preparing substituted chromanol derivatives

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4661596A (en) * 1985-02-21 1987-04-28 American Home Products Corporation Quinolinyl (or pyridinyl) methoxy substituted naphthalene compounds as antiallergic agents
US4719308A (en) 1985-10-03 1988-01-12 American Home Products Corporation Imidazolylmethoxy naphthalene compounds as antiallergic agents
US5059609A (en) * 1987-10-19 1991-10-22 Pfizer Inc. Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases
WO1990015801A1 (en) * 1989-06-22 1990-12-27 Pfizer Inc. Substituted sulfonamides and related compounds in the treatment of asthma, arthritis and related diseases
US4987231A (en) * 1989-08-04 1991-01-22 Pfizer Inc. Optical resolution method for 3R-(3-carboxybenzyl)-6-(5-fluoro-2-benzothiazolyl)methoxy-4R-chromanol
US5641789A (en) * 1992-10-21 1997-06-24 Pfizer Inc. Sulfonamide derivatives of benzenefused hydroxy substituted cycloalkyl and heterocyclic ring compounds

Also Published As

Publication number Publication date
JPH10500143A (ja) 1998-01-06
FI972284A0 (fi) 1997-05-29
MX9703989A (es) 1997-09-30
EP0794951B1 (de) 2000-04-12
FI972284A7 (fi) 1997-05-29
DE69516305D1 (de) 2000-05-18
ES2144628T3 (es) 2000-06-16
CA2204604C (en) 2002-02-19
US5539128A (en) 1996-07-23
DE69516305T2 (de) 2001-02-15
PT794951E (pt) 2000-07-31
EP0794951A1 (de) 1997-09-17
JP3041049B2 (ja) 2000-05-15
GR3033608T3 (en) 2000-10-31
DK0794951T3 (da) 2000-07-10
WO1996016955A1 (en) 1996-06-06
CA2204604A1 (en) 1996-06-06

Similar Documents

Publication Publication Date Title
EG20280A (en) Process for preparing of fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles
IL107843A0 (en) Aminomethylene substituted non-aromatic heterocycles
ES2175087T3 (es) Compuestos triciclicos utiles en el tratamiento de trastornos de proliferacion celular.
CA2134964A1 (en) Bridged Aza-Bicyclic Derivatives as Substance P Antagonists
DE3576331D1 (de) Tetralin-derivate, ihre herstellung und verwendung.
HU9303666D0 (en) Azanorbornane derivatives
DK0726892T3 (da) (E)-20(22)-dehydrovitamin D-forbindelser
ATE242228T1 (de) Verfahren zur herstellung von gamma-butyrolacton sowie dessen verwendung
ES2193241T3 (es) Nuevas n-2-oxo2.3.4.5-tetrajodrp-1h-1,5-benzodiazepin-3-il)-3-amidas.
RU95109929A (ru) Сульфонамидные производные, фармацевтическая композиция и способ лечения млекопитающих
DE69510338D1 (de) Azirdin-derivate, deren herstellung und verwendung
DE69813565D1 (de) Substituierte 3,3-diamino-2-propennitrile, ihre herstellung und verwendung
HU9300533D0 (en) Tropolone derivatives, method for producing them medical preparatives for preventing and treating ischemic diseases containing said compounds and method for preparing them
DE69635057D1 (de) Verfahren zur herstellung von campothecinderivate
DE69516305D1 (de) Verfahren zur herstellung von cis (+) 3-[4,6-dihydroxychroman-3-ylmethyl]-4-methoxyanilin, und zwischenprodukte
DE69514532D1 (de) Indol-2,3-dione-3-oximderivate, ihre herstellung und verwendung
ATE52499T1 (de) 5-alkylsulfonylsalicylanilide und mikrobizide zusammensetzungen fuer die regulierung des wachstums von mikroorganismen.
DE69517371D1 (de) 4-p-fluorbenzoyl-1-piperidinyl-propoxy-chromen-4-on derivate, deren herstellung und deren verwendung zur behandlung von psychosen und schizophrenie
RU94038063A (ru) 3-фенилуреидо-азепин-2-оны и -бензазепин-2-оны, способы их получения, промежуточные соединения, фармацевтические композиции и способы лечения
GB9313145D0 (en) Process
DE69926223D1 (de) Verfahren zur herstellung von zwischenprodukten
DE69404476D1 (de) Verfahren zur herstellung von rufloxacin und salze davon
PH31386A (en) Carboxylic acid leukotriene b4 antagonists.
ATE195072T1 (de) Verwendung von 6,7-substituierten-2- aminotetraline zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von septischem schock, und antipyretischer und antientzündlicher zusammensetzungen
ATE188694T1 (de) Verfahren zur herstellung von benzopyranderivaten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee